Is Skinvive a Filler? Skin Smoothness vs. Volume

The U.S. Food and Drug Administration (FDA) describes Skinvive as a gel implant or filler containing hyaluronic acid. However, the purpose evaluated in its 2023 approval was improving cheek skin smoothness through injection into the dermis. Classification as a filler is not the same as a treatment purpose of adding volume to hollow areas.

Hello, I am Dr. Kim Yeon-jin, Chief Physician at UHCELL Clinic Gangnam.

If you are considering Skinvive, I recommend starting with the change you want rather than the treatment name. If the word “filler” concerns you, consider whether you are worried about a change in facial volume or about the risks of an injectable procedure. These are different concerns and call for different questions.

A skin booster can also be classified as a filler

Our Gangnam clinic’s official treatment information lists Skinvive as a skin booster. The FDA’s 2023 approval overview describes it as a gel implant or filler. Because both descriptions are used for Skinvive, I would not treat “skin booster” and “filler” as mutually exclusive categories.

What I want you to focus on is which product will be injected, where it will be injected, and what change it is intended to achieve. Improving the smoothness of cheek skin should not be interpreted as the same goal as adding volume or changing facial contours.

Hollow cheeks and rough cheek skin are different concerns

The FDA’s dermal filler guidance lists product-specific approved uses that include adding volume to areas such as the cheeks, lips, and chin. Fillers do not all have the same approved treatment areas or purposes. Evidence about Skinvive improving cheek skin smoothness therefore cannot be used as evidence that it fills hollow cheeks.

When preparing for a consultation, I recommend describing your goal in concrete terms:

• If hollowness is your concern: “I would like to address the sunken appearance at the sides of my cheeks.”
• If texture is your concern: “I would like to improve the rough appearance of the skin on my cheeks.”
• If both concern you: “I would like to understand whether to address hollowness or rough skin texture first.”

These are examples of how to communicate your goals, not answers that determine a treatment in advance. Rather than choosing based on the ingredient name “hyaluronic acid,” ask how the intended purpose of the specific product matches your concern.

What the six-month finding actually measured

The FDA’s 2023 approval overview describes a clinical trial involving 209 participants that evaluated improvement in cheek skin smoothness. It reports that the improvement lasted at least six months. To interpret that result, keep the treatment area and measured outcome together: the area was the cheeks, and the outcome was skin smoothness.

I would not present this finding as evidence of improvement in every skin concern across the whole face, or as a guarantee of how long your individual result will last. An observed duration of improvement is also different from a prescribed retreatment interval. This result alone does not mean you must repeat treatment every six months.

The evidence discussed here comes from the U.S. approval materials issued in 2023. If you are considering treatment in Korea, ask about the Korean-approved indications and treatment areas for the product that will be used. The wording of a U.S. approval should not automatically be applied to the scope of treatment in Korea.

A skin-smoothness goal does not remove injection risks

Allergan’s U.S. directions for use for healthcare professionals list injection-site reactions including redness, swelling, bruising, pain, tenderness, firmness, and lumps or bumps. Even when your goal is smoother skin, I recommend taking these possible reactions seriously.

The FDA warns that unintended injection of filler into a blood vessel can block blood flow and cause serious complications, including skin necrosis (tissue death), vision impairment or blindness, and stroke. Although the likelihood is low, the consequences can be serious or permanent.

If you experience a change in vision, unusual pain, or whitening of the skin near the injection site during or shortly after treatment, alert the medical team and seek medical attention immediately. These are symptoms for which the FDA recommends immediate medical attention. I advise against waiting under the assumption that they are simply bruising or part of recovery.

Share your health information as well as your treatment goals

Your health history matters alongside the result you want. Allergan’s U.S. directions for use distinguish between the following conditions:

• Contraindications: Severe allergies manifested by a history of anaphylaxis, a history or presence of multiple severe allergies, or a history of allergy to gram-positive bacterial proteins or lidocaine.
• Conditions in which safety has not been established: Use during pregnancy or breastfeeding. This is not the same category as the contraindications above, but it is information you should disclose.
• Reasons to postpone treatment: Active inflammation or infection at the treatment site. The directions advise delaying injection until the condition is controlled.
• Medication precautions: Medicines that can prolong bleeding, such as aspirin, nonsteroidal anti-inflammatory drugs, and warfarin, may increase bruising or bleeding at the injection site.

I recommend preparing a list of your allergy history and medications, and noting whether you are pregnant or breastfeeding or have inflammation or infection in the proposed treatment area. These points come from U.S. product safety information. A decision about treatment in Korea should also take into account the Korean-approved labeling for the product being used and your individual condition.

You can review our Gangnam clinic’s Skinvive treatment information before your consultation. I recommend beginning the discussion with a clear goal: do you want to change cheek volume, improve cheek skin texture, or discuss both?

※ Skin reactions and recovery times vary by individual. Please consult a medical professional for an accurate diagnosis and treatment plan.